Skip to main content
HR 5219 114th Congress House

Safe Medications for Moms and Babies Act of 2016

Official title: To provide for the establishment of the Task Force on Research Specific to Pregnant Women and Lactating Women, to require an annual report to Congress on appro… Show full official titleShow less

Official title: To provide for the establishment of the Task Force on Research Specific to Pregnant Women and Lactating Women, to require an annual report to Congress on approved new drug applications with information on pregnancy and lactation, and for other purposes.

Introduced: September 28, 2016 See on congress.gov
Health Administrative law and regulatory proceduresAdvisory bodiesChild healthCongressional oversight
More subjectsShow fewer subjects
Department of Health and Human ServicesDrug safety, medical device, and laboratory regulationMedical ethicsMedical researchPrescription drugsResearch administration and fundingWomen's health
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 13, 2016
Referred to the Subcommittee on Health.
May 12, 2016
Referred to the House Committee on Energy and Commerce.
May 12, 2016
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 13, 2016

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Safe Medications for Moms and Babies Act of 2016

This bill requires the Department of Health and Human Services to establish the Task Force on Research Specific to Pregnant Women and Lactating Women to report on issues including: (1) the development of safe and effective therapies for such women, (2) ethical issues surrounding the inclusion of such women in clinical research, and (3) federal research activities regarding such women.

The Food and Drug Administration must report specified information including the number of new drugs approved based on research that included such women in clinical trials.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 3
D
Pingree, Chellie
Maine · Sep 28, 2016
 D
Wasserman Schultz, Debbie
Florida · Sep 6, 2016
Costello, Ryan
· Jun 21, 2016
 D
Castor, Kathy
Florida · May 12, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5219: Safe Medications for Moms and Babies Act of 2016. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5219/
MLA
"H.R. 5219: Safe Medications for Moms and Babies Act of 2016." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5219/.
Bluebook (legal)
H.R. 5219, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5219/.
Markdown link
[H.R. 5219: Safe Medications for Moms and Babies Act of 2016](https://openamerica.io/bill/114-HR-5219/)
Report a problem